Earnings History Data for Vivos Therapeutics (VVOS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Vivos Therapeutics
Vivos Therapeutics Inc. is a medical technology company. It engages in the development and commercialization of technology solutions for patients with sleep disordered breathing comprising mild-to-moderate obstructive sleep apnea. Vivos Therapeutics Inc. is based in Highlands Ranch, Colorado.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2024 | AH | VVOS | Vivos Therapeutics | 15.00 | -0.40 | -0.70 | 0.00 | Vivos Therapeutics GAAP EPS of -$0.40, revenue of $3.86M [11/15/2024 10:02 AM] |
2.86 | -0.26 (-8.33%) |
3.02 | -0.10 (-3.20%) |
1.91 - 48.79 | 218,663 | 180,000 | 3,458 | ||
|
||||||||||||||||||
| 14-11-2023 | AH | VVOS | Vivos Therapeutics, Inc. | 3.28 | -1.75 | -3.25 | -6.50 | Vivos Therapeutics GAAP EPS of -$1.75 beats by $1.38, revenue of $3.3M misses by $0.84M [11/14/2023 4:18 PM] |
3.87 | 0.14 (3.75%) |
4.17 | 0.44 (11.80%) |
2.73 - 74.05 | 71,290 | 50,000 | 1,358 | ||
| 14-08-2023 | AH | VVOS | Vivos Therapeutics, Inc. | 10.27 | -0.20 | -0.15 | -0.33 | 0.3267 | -0.02 (-4.78%) |
0.33 | -0.01 (-3.00%) |
0.23 - 2.96 | 354,942 | 8,370,000 | 67,725 | |||
|
|
||||||||||||||||||
| 08-06-2023 | AH | 4:15 PM ET (Jun 8) |
VVOS | Vivos Therapeutics, Inc. | 12.25 | -0.20 | -0.17 | -0.26 | Vivos Therapeutics GAAP EPS of -$0.07 beats by $0.10, revenue of $3.86M misses by $0.15M [6/8/2023 4:22 PM] |
0.4222 | -0.05 (-10.17%) |
0.46 | -0.01 (-2.00%) |
0.30 - 2.96 | 219,180 | 140,000 | 13,774 | |
| 30-03-2023 | PM | 4:15 PM ET (Mar 30) |
VVOS | Vivos Therapeutics, Inc. | 18.76 | -0.20 | -0.22 | -0.34 | Vivos Therapeutics GAAP EPS of -$1.04, revenue of $16.02M [3/31/2023 3:03 AM] |
0.3410 | -0.02 (-5.28%) |
0.34 | -0.02 (-5.00%) |
0.30 - 2.96 | 308,785 | 170,000 | 4,552 | |
| 20-12-2022 | AH | 4:05 PM ET (Dec 20) |
VVOS | Vivos Therapeutics, Inc. | 8.02 | -0.33 | -0.25 | -0.26 | Vivos Therapeutics GAAP EPS of -$0.26, revenue of $4.2M [12/20/2022 4:21 PM] |
0.4111 | -0.12 (-22.43%) |
0.48 | -0.05 (-8.68%) |
0.34 - 3.69 | 340,764 | 170,000 | 19,188 | |
| 16-05-2022 | AH | 4:05 PM ET (May 16) |
VVOS | Vivos Therapeutics, Inc. | 29.69 | -0.26 | -0.29 | -0.19 | Vivos Therapeutics GAAP EPS of -$0.26 in-line, revenue of $3.46M misses by $0.98M [5/16/2022 4:11 PM] |
1.57 | 0.22 (16.01%) |
0.0 | 0.0 (0.00%) |
1.18 - 7.09 | 147,236 | 110,000 | 0 | |
| 15-11-2021 | AH | 4:05 PM ET (Nov 15) |
VVOS | Vivos Therapeutics, Inc. | 89.42 | -0.26 | -0.16 | 0.00 | Vivos Therapeutics EPS misses by $0.08, beats on revenue [11/15/2021 4:20 PM] |
3.25 | -0.81 (-19.95%) |
3.56 | -0.50 (-12.32%) |
2.61 - 14.41 | 499,213 | 80,000 | 3,170 | |
| 12-08-2021 | AH | 4:05 PM ET (Aug 12) |
VVOS | Vivos Therapeutics, Inc. | 63.87 | -0.19 | -0.16 | 0.00 | 3.28 | 0.54 (19.71%) |
2.80 | 0.06 (2.19%) |
2.61 - 14.41 | 3,130,127 | 230,000 | 10,708 | ||
| 17-05-2021 | AH | 4:05 PM ET (May 17) |
VVOS | Vivos Therapeutics, Inc. | 103.60 | -0.19 | -0.17 | 0.00 | Vivos Therapeutics EPS misses by $0.02, beats on revenue [5/17/2021 4:23 PM] |
5.79 | -0.27 (-4.46%) |
6.16 | 0.10 (1.65%) |
5.64 - 14.41 | 94,374 | 310,000 | 1,300 | |
|
||||||||||||||||||
| 25-03-2021 | AH | After the close (Mar 25) |
VVOS | Vivos Therapeutics, Inc. | 122.50 | -0.48 | -0.21 | 0.00 | Vivos Therapeutics EPS misses by $0.93, beats on revenue [3/25/2021 4:54 PM] |
6.93 | 0.09 (1.32%) |
7.45 | 0.61 (8.92%) |
5.64 - 14.41 | 54,828 | 140,000 | 15,505 | |